These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3069689)

  • 21. Divergent effects of the catalytic and bridging functions of hepatic lipase on atherosclerosis.
    Dichek HL; Qian K; Agrawal N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1696-702. PubMed ID: 15205216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lipid determination in current medical practice].
    Bakir R; Chanu B; Rouffy J
    Ann Dermatol Venereol; 1986; 113(9):855-9. PubMed ID: 3827091
    [No Abstract]   [Full Text] [Related]  

  • 23. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 24. [Metabolism and possible mechanisms of atherogenesis induced by lipoprotein (a)].
    Krempler F
    Wien Klin Wochenschr Suppl; 1984; 151():1-12. PubMed ID: 6091345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lipoprotein lipase inhibitory factor].
    Kihara S
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):88-90. PubMed ID: 9645015
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lipids and lipoproteins in atherosclerotic arteriopathy of the legs. Unusual study of very low density lipoproteins].
    Duchassaing D; Dezellus P; Guenée B; Tenenhaus D; Jarnet J; Paris M; Housset E; Leclerc M
    Pathol Biol (Paris); 1985 Nov; 33(9):881-5. PubMed ID: 3909080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipoprotein metabolism in arterial walls and its relationship with the genesis of atheromatous lesion].
    Gaeta G; Effuso L; Maurea N; Boccalatte M; Scala R; Sifola C; Antignano A
    Clin Ter; 1994 Jan; 144(1):63-72. PubMed ID: 8168354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Disorders of lipoprotein metabolism as a risk factor in atherosclerosis in patients with glomerulonephritis].
    Nikulina GG; Petrun' NM; Mel'man NIa; Zel'dich IM; Serbina IE
    Vrach Delo; 1983 Aug; (8):53-6. PubMed ID: 6636687
    [No Abstract]   [Full Text] [Related]  

  • 29. [The vasoactive properties of different classes of blood lipoproteins in hypercholesterolemia and atherosclerosis].
    Frol'kis VV; Kul'chitskiĭ OK; Novikova SN; Sykalo NV; Potapenko RI; Mozzhukhina TG; Bogatskaia LN; Burchinskaia MK
    Patol Fiziol Eksp Ter; 2000; (1):15-7. PubMed ID: 10741181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine models for study of lipoprotein metabolism and atherosclerosis.
    Witztum JL
    J Clin Invest; 1993 Aug; 92(2):536-7. PubMed ID: 8349795
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemia.
    Bilheimer DW; East C; Grundy SM; Nora JJ
    Am J Med Genet; 1985 Nov; 22(3):593-8. PubMed ID: 4061492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein(a): a hereditary risk factor for atherosclerotic disease.
    Donders SH; van Wersch JW
    Neth J Med; 1992 Feb; 40(1-2):96-104. PubMed ID: 1533703
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of atherogenic lipoproteins on PAI-1 synthesis by endothelial cells.
    Camera M; Mussoni L; Maderna P; Sironi L; Prati L; Colli S; Bernini F; Corsini A; Tremoli E
    Cytotechnology; 1993; 11 Suppl 1():S144-6. PubMed ID: 7763745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Synthesis and properties of an affinity sorbent for extraction of atherogenic lipoproteins].
    Andrianova IP; Rabovskiĭ AB; Zuevskiĭ VV; Tsybul'skaia MV; Samoĭlova NA
    Bioorg Khim; 1986 Oct; 12(10):1391-5. PubMed ID: 3468950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes in the fractions of atherogenic and antiatherogenic lipoproteins in patients with chronic bronchitis].
    Ionov VA
    Vrach Delo; 1990 May; (5):64-6. PubMed ID: 2396396
    [No Abstract]   [Full Text] [Related]  

  • 36. Retention of atherogenic lipoproteins in atherogenesis.
    Gustafsson M; Flood C; Jirholt P; Borén J
    Cell Mol Life Sci; 2004 Jan; 61(1):4-9. PubMed ID: 14704849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lipoprotein (a): a strong risk factor in atherosclerosis].
    Maranhão RC; Pileggi F
    Arq Bras Cardiol; 1990 May; 54(5):337-42. PubMed ID: 2149632
    [No Abstract]   [Full Text] [Related]  

  • 38. [The psychological characteristics of adolescents with ischemic heart disease in their anamnesis and their linkage to the lipoprotein spectrum indices].
    Leont'eva IV; Metel'skaia VA; Sipiagina AE; Dobrynina MV; Aĭngorn ED
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(3):51-5. PubMed ID: 7975990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atherosclerosis: cell biology and lipoproteins.
    Brown AJ
    Curr Opin Lipidol; 1995 Apr; 6(2):U47-54. PubMed ID: 7773565
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipoproteins and atherosclerosis in diabetes mellitus.
    Schonfeld G
    Biochem Soc Trans; 1989 Feb; 17(1):53-5. PubMed ID: 2653915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.